Journal of Hepatology

5 ta ish

Jurnal · ISSN 0168-8278

1. 50 ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: INTERIM RESULTS OF STUDY C209

   Graham R. Foster, Christophe Hézode, J.‐P. Bronowicki +7

   MaqolaHepatitis C virus researchJournal of Hepatology20090 iqtibos

   ABIABI:AkademIndex/openalex/2009.article.000028

2. 49 PEGINTRON MAINTENANCE THERAPY IN CIRRHOTIC (METAVIR F4) HCV PATIENTS, WHO FAILED TO RESPOND TO INTERFERON/RIBAVIRN (IR) THERAPY: FINAL RESULTS OF THE EPIC3 CIRRHOSIS MAINTENANCE TRIAL

   Jordi Bruix, Thierry Poynard, Massimo Colombo +16

   MaqolaHepatocellular Carcinoma Treatment and PrognosisJournal of Hepatology20090 iqtibos

   ABIABI:AkademIndex/openalex/2009.article.000125

3. 51 RESPONSE RATE ACCORDING TO WHO, RECIST AND EASL CRITERIA AFTER RADIOEMBOLIZATION OF YTTRIUM-90 GLASS MICROSPHERES IN ADVANCED HEPATOCELLULAR CARCINOMA: A EUROPEAN PILOT PHASE II STUDY

   Amr El Fouly, Justin Ertle, G Antoch +5

   MaqolaHepatocellular Carcinoma Treatment and PrognosisJournal of Hepatology20090 iqtibos

   ABIABI:AkademIndex/openalex/2009.article.000412

4. P1236 : Impact of high portal pressure on renal hemodynamics in children with portal hypertension

   R. Z. Yuldashev, М. М. Алиев, Gulnara S. Adilova

   MaqolaLiver Disease and TransplantationJournal of Hepatology20150 iqtibos

   ABIABI:AkademIndex/openalex/2015.article.000597

5. Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies

   Homie Razavi, Imam Waked, Huma Qureshi +97

   MaqolaHepatitis C virus researchJournal of Hepatology20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.000135